Vanguard Group Inc. Sells 461,225 Shares of Masimo Corporation $MASI

Vanguard Group Inc. cut its holdings in Masimo Corporation (NASDAQ:MASI) by 9.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,348,786 shares of the medical equipment provider’s stock after selling 461,225 shares during the period. Vanguard Group Inc. owned approximately 0.08% of Masimo worth $565,603,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Masimo by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after purchasing an additional 66 shares during the last quarter. Clearstead Advisors LLC increased its position in shares of Masimo by 18.4% in the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73 shares during the period. Assetmark Inc. increased its position in shares of Masimo by 5.5% in the fourth quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after acquiring an additional 97 shares during the period. Orion Porfolio Solutions LLC increased its position in shares of Masimo by 2.2% in the second quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock valued at $819,000 after acquiring an additional 104 shares during the period. Finally, Smartleaf Asset Management LLC increased its position in shares of Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 136 shares during the period. 85.96% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

MASI has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research report on Tuesday, February 17th. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Finally, BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Eight equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $181.17.

Masimo Price Performance

Shares of MASI opened at $178.21 on Tuesday. The stock has a market cap of $9.57 billion, a PE ratio of -16.91, a price-to-earnings-growth ratio of 1.81 and a beta of 1.13. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. Masimo Corporation has a fifty-two week low of $125.94 and a fifty-two week high of $179.00. The firm’s 50-day simple moving average is $177.21 and its two-hundred day simple moving average is $153.98.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.